CHARACTERISTICS OF DIFFICULT TO TREAT PSORIATIC ARTHRITIS: A COMPARATIVE ANALYSIS

被引：1
|
作者：
Philippoteaux, C. [1 ]
Marty-Ane, A. [1 ]
Martin, C. [2 ]
Philippe, P. [1 ]
Paccou, J. [1 ]
Cortet, B. [1 ]
Flipo, R. M. [1 ]
Letarouilly, J. G. [1 ]
机构：
[1] Lille Univ Hosp, Rheumatol, Lille, France
[2] Lille Univ Hosp, Datamanagement Unit, Stat Econ Evaluat, Lille, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1333
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1521
引用
收藏
页码：1121 / 1121
页数：1
相关论文
共 50 条
  • [21] Comparative analysis between ankylosing spondylitis and axial psoriatic arthritis patients
    Abdelaziz, Marwa Mahmoud
    Ismail, Nadia
    Gamal, Aya M.
    Lafy, Raghda
    El-Adly, Wael
    EGYPTIAN RHEUMATOLOGIST, 2022, 44 (01) : 25 - 29
  • [22] Computational analysis of micro RNAs compatibility in pharmacogenomic based regulatory networks of psoriatic arthritis: An initiation towards identifying a potential miRNA to treat psoriatic arthritis
    Anandaram, Harishchander
    Anand, Daniel Alex
    BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY, 2018, 16 : 545 - 547
  • [23] FATIGUE AND PSORIATIC ARTHRITIS: WHAT CHARACTERISTICS?
    Ben Amou, A.
    Rahmouni, S.
    Tbini, H.
    Zouaoui, K.
    Rekik, S.
    Boussaid, S.
    Sahli, H.
    Elleuch, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1806 - 1807
  • [24] Treat to Target in Psoriatic Arthritis—Evidence, Target, Research Agenda
    Laura C. Coates
    Philip S. Helliwell
    Current Rheumatology Reports, 2015, 17
  • [25] SECUKINUMAB: IL-17A INHIBITION TO TREAT PSORIATIC ARTHRITIS
    Speeckaert, R.
    van Geel, N.
    Lambert, J.
    Claeys, L.
    Delanghe, J. R.
    Speeckaert, M. M.
    DRUGS OF TODAY, 2016, 52 (11) : 607 - 616
  • [26] Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
    L. Widawski
    T. Fabacher
    L. Spielmann
    JE. Gottenberg
    J. Sibilia
    PM. Duret
    L. Messer
    R. Felten
    Clinical Rheumatology, 2022, 41 : 1421 - 1429
  • [27] Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
    Widawski, L.
    Fabacher, T.
    Spielmann, L.
    Gottenberg, J. E.
    Sibilia, J.
    Duret, P. M.
    Messer, L.
    Felten, R.
    CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1421 - 1429
  • [28] What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis?
    Coates, Laura C.
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    Emery, Paul
    Conaghan, Philip G.
    Helliwell, Philip S.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (01) : 38 - 42
  • [29] The role of ultrasound and magnetic resonance imaging for treat to target in rheumatoid arthritis and psoriatic arthritis
    Mandl, Peter
    Aletaha, Daniel
    RHEUMATOLOGY, 2019, 58 (12) : 2091 - 2098
  • [30] Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project
    Singla, Shikha
    Ribeiro, Andre
    Torgutalp, Murat
    Mease, Philip J.
    Proft, Fabian
    RMD OPEN, 2024, 10 (01):
12345